Melrose Industries PLC

Overview

This report applies Joel Greenblatt's Magic Formula approach to Melrose Industries PLC (LSE:MRO), a pure-play aerospace components manufacturer. The analysis focuses on two key metrics: Earnings Yield (EBIT / Enterprise Value) to measure cheapness, and Return on Capital (EBIT / (Net Working Capital + Net Fixed Assets)) to measure business quality, with the goal of identifying a high-quality company trading at a discount.

Business Quality Assessment

Melrose possesses a wide economic moat built on its Risk and Revenue Sharing Partnerships (RRSPs) covering ~70% of global flight hours, sole-sourced positions on critical aerospace structures, and a multi-decade aftermarket tailwind. Return on Capital (ROC) is exceptionally high. Using statutory EBIT of £600m and tangible invested capital of approximately £2,013m (Net Working Capital £962m + Net Fixed Assets £1,051m), ROC is ~29.8%. Using adjusted EBIT of £647m yields ~32.1%. These returns are sustainable due to high barriers to entry, proprietary technology (additive fabrication, advanced composites), and multi-year contracts with OEMs. Historically, ROC has been suppressed by restructuring charges; with the transformation complete, ROC is expected to expand further as aftermarket cash flows accelerate.

Valuation Analysis

Enterprise Value (EV) = Market Cap (£6.077bn) + Net Debt (£1.407bn) = £7.484bn. Earnings Yield = EBIT / EV. Using statutory EBIT of £600m gives an earnings yield of 8.0%. Using adjusted EBIT of £647m gives 8.6%. This compares favorably to the UK 10-year gilt yield (~4.5%) and the average earnings yield of the FTSE 100 (~6-7%). The stock trades at a forward P/E of ~10.5x, well below the sector average of 15-20x for aerospace peers like Safran, MTU Aero, and Howmet Aerospace. On an EV/EBIT basis, the stock trades at ~11.6x, which is cheap relative to its intrinsic growth and margin profile.

Magic Formula Ranking

Normalized Earnings Analysis

Current earnings (statutory EBIT £600m) are representative of normalized earnings power after adjusting for one-time restructuring and volatile items. The multi-year transformation programme is complete, so restructuring costs of £34m (2025) will fade. Adjusting items included £232m net derivative gains (non-cash, hedge accounting not applied) – these are volatile and should be excluded. Normalized adjusted EBIT is closer to £647m. Amortization of acquired intangibles (£252m) is a real charge but non-cash; for 'owner earnings' we consider EBIT after maintenance capex. Maintenance capex is ~£94m vs. depreciation of owned assets ~£100m. Free cash flow (after interest and tax) was £125m and is guided to £150-200m in 2026. Sustainable owner earnings (EBIT(1-t) + depreciation - maintenance capex) approximate £450-500m, giving a normalized earnings yield on EV of ~6-7% after tax. The company is in an inflection point where cash generation will ramp significantly toward £600m by 2029.

Why The Market Is Wrong

The market sold off ~14% on Feb 27, 2026, after 2026 guidance (£700-750m operating profit) slightly missed consensus (£754m). This is a classic short-term overreaction. The Airframes division faced temporary headwinds: supply chain constraints at OEMs and a productivity issue in a Netherlands facility. These are fixable and do not alter the multi-year thesis. The underlying demand is structural: record aircraft backlogs (~15,000 units), increasing defence spending, and a multi-decade aftermarket supercycle. The market is ignoring the inflection point in free cash flow (positive £125m in 2025, guiding to £150-200m in 2026, and £600m by 2029). Management is demonstrating confidence with a £175m share buyback, and the GTF engine cash drag will turn positive in 2028. The contrarian case is that near-term noise masks the compounding machine being built.

Key Risks

Conclusion

Melrose Industries offers a rare combination of high quality (30%+ return on tangible capital) and attractive valuation (8%+ earnings yield). The market's focus on minor near-term guidance misses ignores the structural tailwinds from record aerospace backlogs, defence spending increases, and a free cash flow inflection that will compound shareholder returns. The buyback program and dividend growth signal management confidence. At 487p, the stock trades at a significant discount to intrinsic value (Morningstar FVE 800p, consensus 707p). For the patient investor following Greenblatt's 1-year holding period, this is exactly the type of situation the Magic Formula is designed to exploit.

Overview

This is a Druckenmiller-style macro investment analysis of Melrose Industries PLC (LSE:MRO), a UK-listed aerospace and defence technology company. The analysis examines Melrose through the lens of top-down macro analysis, reflexivity, and asymmetric risk/reward positioning, focusing on the company's transformation into a pure-play aerospace business and its positioning within structural growth markets driven by defence spending increases, civil aviation recovery, and aftermarket demand.

Macro Context

The global macro environment presents a compelling backdrop for aerospace and defence exposure. Defence spending is experiencing a generational inflection point - NATO members have committed to increasing spending targets from 2% to 3.5% of GDP, Europe's ReArm Europe Plan targets €800bn by 2029, and the US is proposing a 50%+ defence budget increase to $1.5 trillion for 2027. Central bank policy remains accommodative enough to support industrial capex cycles, while geopolitical tensions (Russia-Ukraine, Middle East, China-Taiwan) create sustained demand tailwinds. The civil aerospace cycle is recovering post-COVID with record order backlogs stretching into the 2030s - Airbus and Boeing have combined backlogs of 13,000+ aircraft. Flight hours are growing at 6% CAGR through 2030, driving aftermarket demand. Supply chain constraints, while creating near-term revenue headwinds, are actually extending aircraft life cycles and boosting higher-margin aftermarket and repair revenues. Currency dynamics favor UK-listed companies with significant USD revenue exposure as the dollar strengthens.

Company Position in Macro Landscape

Melrose is exceptionally well-positioned within current macro themes. As a 'Super-Tier 1' aerospace supplier with embedded positions on all major civil and defence platforms, the company sits at the intersection of multiple structural tailwinds: (1) Defence ramp - 29% of revenues, with content on F-35, Gripen, Apache, C-130, Eurofighter; defence revenue grew 15% in 2025; (2) Civil aviation recovery - 71% of revenues, sole-sourced on 70% of airframe content, stronger Airbus weighting advantageous given Boeing's struggles; (3) Aftermarket/MRO growth - higher-margin recurring revenue stream growing double-digits; (4) Additive manufacturing leadership - proprietary technology creating competitive moat and new revenue streams. The completed multi-year transformation program has repositioned Melrose from a conglomerate to a focused aerospace pure-play with 18% operating margins (up 240bps YoY) and positive free cash flow inflection (£125m in 2025 vs -£74m in 2024).

Reflexivity Analysis

Several self-reinforcing feedback loops are emerging: (1) POSITIVE LOOP - Cash generation enabling buybacks and dividends → share price support → lower cost of capital → ability to invest in additive manufacturing capacity → competitive differentiation → higher margins → more cash generation. The £175m new buyback program and 20% dividend growth reinforce this cycle. (2) POSITIVE LOOP - Defence contract wins → track record → more contract opportunities → revenue diversification → reduced cyclicality → valuation re-rating. Over 90% of defence portfolio now sustainably priced. (3) NEGATIVE LOOP RISK - Supply chain constraints → OEM production delays → revenue headwinds → potential margin pressure if fixed costs can't flex. However, this is partially offset by aftermarket benefit. (4) RRSP MATURATION - The 19 Risk and Revenue Sharing Partnerships are creating predictable long-duration cash flows as engines mature - variable consideration of £324m in 2025, expected to reach £500m by 2029. Market sentiment has turned cautious following the 15% stock drop on softer-than-expected 2026 revenue guidance (£3.75-3.95bn vs consensus £4.01bn), creating potential entry opportunity if supply chain concerns prove transitory.

Competitive Position & Disruptive Threats

Melrose occupies an enviable competitive position with significant barriers to entry: (1) Design-led embedded relationships - content locked in for life of aircraft programs (often 30+ years); (2) Regulatory moats - aerospace certification requirements create 5-7 year lead times for competitors; (3) Technology leadership - world's first FAA-certified major additive fabrication component (Fan Case Mount Ring), partnerships with all engine OEMs (P&W, GE, Rolls-Royce, CFMI RISE); (4) Scale advantages - 30+ manufacturing sites across 12 countries, £300m+ committed investment in additive manufacturing; (5) Customer concentration provides stability - relationships spanning 20+ years with primes (Lockheed Martin, BAE Systems, Airbus, Boeing). Disruptive threats are limited given industry structure - new entrant risk is minimal due to capital intensity and certification barriers. Primary competitive risk is execution (Netherlands site productivity issues affecting margins) rather than displacement. The shift to electric/hydrogen propulsion represents long-term transformation risk but Melrose is actively positioning (Archer partnership, H2GEAR, EWIS capabilities).

Asymmetric Risk/Reward

The current setup presents attractive asymmetry: UPSIDE CASE (40-50% probability): Supply chain normalization, OEM ramp execution, defence spending acceleration → 2029 targets achievable (£5bn revenue, £1.2bn+ operating profit, £600m FCF, representing 24%+ margins). At current valuation, this implies significant re-rating potential. Forward P/E of 12x on EPS growing 20%+ CAGR is undemanding for aerospace. Price target: 750-850p (JPMorgan target 750p). BASE CASE (35-40% probability): Continued supply chain challenges moderate growth but underlying trends intact. Revenue/profit slightly below guidance mid-points but FCF inflection sustained. Fair value: 650-700p. DOWNSIDE CASE (15-20% probability): Extended supply chain disruption, Boeing/Airbus production cuts, defence budget sequestration risk. Downside to 450-500p (trough valuation on depressed earnings). CONVEXITY: The RRSP portfolio provides embedded optionality - as GTF programs turn cash-positive in 2028, FCF could exceed expectations. Additive manufacturing represents call option on new revenue streams (targeting £50m+ incremental profit by decade end). Entry point attractiveness is enhanced by the 17%+ pullback from 52-week highs, with stock now trading below both 50-day (625p) and 200-day (582p) moving averages.

Key Risks

Investment Details

Overview

This is a deep value and contrarian analysis of Melrose Industries PLC (LSE:MRO), a UK-based aerospace and defense company that has transformed from a 'buy, improve, sell' industrial turnaround specialist into a pure-play aerospace technology business following the demerger of its automotive division (Dowlais) in 2023. The company now operates through two divisions - Engines and Structures - with design-led positions on virtually all major aircraft platforms globally. Despite strong operational progress and a clear path to significant cash flow generation, the stock trades at what appears to be a substantial discount to intrinsic value, creating a potential opportunity for patient investors willing to hold through the company's cash flow inflection point.

The Bear Case

Wall Street's skepticism centers on several legitimate concerns: First, the company has been unable to generate positive free cash flow for three consecutive years as a standalone aerospace business, with heavy restructuring costs and GTF powder metal inspection payments creating persistent cash drains. Second, the high price-to-book ratio of 273x appears alarming on the surface, suggesting limited asset backing. Third, the Structures division operates in what analysts describe as 'one of the least attractive areas of commercial aerospace' with weak pricing power and complex supply chains. Fourth, currency headwinds have forced management to revise guidance downward - the FX translation from $1.25 to $1.335 reduced operating profit guidance by £30-40 million. Fifth, UBS maintains a 'sell' rating with a price target of just 410p (vs. current 610p), arguing the Engines RRSP 'cash mountain' is worth only half of management's estimate. Finally, the stock has underperformed the UK market and aerospace peers like Rolls-Royce, which has risen over 1,285% in three years while Melrose has struggled. Supply chain disruptions and tariff uncertainty add further operational complexity.

The Bull Case

The contrarian thesis rests on several powerful but underappreciated factors: First, 2025 marks a critical inflection point - management guides to £100+ million positive free cash flow, with restructuring cash outflows ending this year. The £91 million YoY improvement in H1 2025 FCF validates this trajectory. Second, the Engines division possesses an irreplaceable portfolio of 19 Risk and Revenue Sharing Partnerships covering ~70% of global flying hours, creating a multi-decade annuity stream. Six engines (V2500, CFM56, GEnx, XWB, GTF variants) drive 90% of future RRSP value. Third, the market ignores that 17 of 19 RRSPs are already in cash-generative phase, with the problematic GTF programs expected to turn cash-positive by 2028. Fourth, over 70% of revenue is sole-sourced, creating exceptional competitive moats. Fifth, the defense spending surge - NATO targeting 5% of GDP by 2035 and Europe's €800 billion ReArm plan - provides a significant tailwind not yet reflected in 2029 targets. Sixth, management's 2029 targets of £5 billion revenue, £1.2 billion+ operating profit, and £600 million free cash flow imply massive earnings growth (>20% CAGR) with the stock trading at just ~15x forward earnings. Seventh, Morningstar assigns a WIDE economic moat and an 800p fair value estimate - 31% above current price. Finally, the company is actively returning capital through £250 million buybacks and 20% dividend growth.

Fundamental Deep Dive

Sentiment & Technical Setup

Catalyst Analysis

Multiple catalysts could drive a re-rating: 1) Q4 2025 results (February 2026) should confirm £100m+ free cash flow achievement - the first positive FCF year as a standalone company. 2) Completion of restructuring program by year-end 2025 eliminates a major cash drain. 3) GTF powder metal resolution progressing well, with headwinds expected to fade in 2027 and programs turning cash-positive in 2028. 4) Defense spending surge from NATO/European rearmament not yet in 2029 targets - provides upside optionality. 5) Additive fabrication commercialization accelerating - 100% serial production on Fan Case Mount Ring by end-2025, with a growing pipeline of parts to certify. 6) Continued execution on 85% defense repricing achievement demonstrates management credibility. 7) Potential strategic review of Structures division could unlock value - Senior recently received a 'surprisingly generous payment' for its structures business. 8) Ongoing £250 million share buyback (£150 million remaining) provides price support. 9) Dividend growth of 20% annually signals confidence. 10) Any evidence of accelerating OEM production rates would boost sentiment.

Key Risks

Conclusion

Melrose Industries represents a classic deep value opportunity where near-term operational noise obscures exceptional long-term fundamentals. The market is pricing in perpetual cash consumption when the company is demonstrably at an inflection point - H1 2025 showed £91 million FCF improvement and management confidently guides to £100m+ for the full year. The Engines division's RRSP portfolio is essentially a toll booth on global aviation, collecting royalties on ~70% of flying hours for decades to come. At ~15x forward earnings versus peers like Rolls-Royce at 41x and GE Aerospace at similar multiples, Melrose trades at a substantial discount despite comparable quality assets. Morningstar's 800p fair value estimate implies 31% upside, while the company's own 2029 targets (if achieved) suggest the stock could trade significantly higher. The wide economic moat from sole-sourced positions, design-led relationships embedded for program lifetimes, and breakthrough additive fabrication technology are not adequately reflected in the current valuation. The defense spending surge provides upside optionality not in current targets. Key risks are real but manageable, and the company's conservative balance sheet (2.0x leverage with £693m liquidity headroom) provides margin of safety. This is a patient investor's opportunity to buy a high-quality aerospace compounder before the market recognizes the cash flow transformation.

Overview

This report analyzes Melrose Industries PLC (LSE:MRO), an aerospace and defense Tier‑1 supplier, using William J. O’Neil’s CAN SLIM framework. It synthesizes the latest company-reported results and guidance with market data to assess growth, quality, and timing for investors.

Financial and Business Overview

Business model: Melrose is now a pure-play global aerospace and defense technology group operating through two divisions: Engines (risk-and-revenue-sharing partnerships, non-RRSP OE, repairs, and governmental) and Structures (design-to-build aerostructures, EWIS, transparencies). It is a ‘Super-Tier 1’ partner with embedded, often sole-source positions across leading civil and defense platforms. Scale and profitability: 2025 guidance (at $/£ 1.335) calls for £3.425–£3.575bn revenue and £620–£650m adjusted operating profit with Group margins ~18% for 2025; H1 2025 adjusted operating profit rose 29% YoY to £310m with margin up 380 bps to 18.0% (Engines margin 33.4%, Structures 6.7%). Adjusted diluted EPS in H1 2025 was 15.1p (+30% YoY). Cash and leverage: Free cash flow is guided to £100m+ for 2025; H1 free cash outflow improved by £91m to £54m due to higher earnings and lower restructuring. Net debt at 30 June 2025 was £1.404bn (2.0x ND/EBITDA), within covenant headroom. Buybacks of £250m are underway (c.£91m completed by H1 2025). Balance sheet snapshot (FY 2024): Total assets £7.44bn, liabilities £4.59bn, equity £2.84bn; book value per share ~£2.21. Working capital was negative (FY 2024 working capital -£171m) reflecting typical aero program cash dynamics and customer advances. Valuation and trading: Price 634.6p (GBp), trailing P/E ~25.4x on TTM EPS ~25p; P/B ~2.9x (price ~£6.35 vs book ~£2.21). Dividend ~6.0p (≈1% yield). Average analyst rating: Buy.

Market Position & Competitive Advantages

Position: Embedded, life-of-program content across 19 engine RRSPs (≈70% of global flight hours coverage) plus broad Structures content with >70% sole-source civil/defense positions. Structural tailwinds include record civil backlogs (narrowbody/widebody) and accelerated defense outlays (NATO/EU), driving OE ramps and aftermarket growth for decades. Moats and advantages: - High switching costs: Design-led, certified content integrated into platforms for program life. - Aftermarket annuity: Mature engines (e.g., V2500, CFM56) plus growing fleets (GEnx, XWB, GTF) provide multi-decade cash flows; Engines margin already >33%. - Technology leadership: Breakthrough additive fabrication (first and only certified major structural engine component in serial transition by end-2025), participation in next-gen engines (CFM RISE, next-gen GTF), and advanced composites/EWIS. - Operational transformation: Multi-year footprint consolidation (52 to 32 sites), repricing (85% of defense portfolio sustainably repriced 6 months early), lean ‘Brilliant Basics’ driving safety/quality/productivity gains. Key risks (be honest): - Tariffs/supply chain: US tariff regime and aerospace casting/forging constraints create complexity and working capital friction (mitigations in place but residual risk persists). - Concentration & program risk: GTF powder metal remediation costs (~£70m in 2025/26) and pacing of OE build rates can affect variable consideration timing and cash flows. - Leverage and cash conversion: Leverage ~2.0x; FCF inflects in 2025 but remains modest this year; variable consideration accounting and negative working capital require disciplined execution. - Governance optics: Shareholders rejected the directors’ remuneration report at the 2025 AGM (non-binding), highlighting sensitivity to pay alignment.

Stock Performance

Price: 634.6p; 52-week range 376p–682.6p; currently ~7% below the 52-week high and ~35% above the 52-week low. 50-day average ~607p; 200-day average ~542p, indicating an established uptrend. One-year total price change ~+34.9%. Average daily volume ~3.6m shares. The share has been resilient on improving margins, clearer cash inflection, and buyback support, with episodic volatility around tariff headlines and FX.

CAN SLIM Analysis

Conclusion

Melrose aligns well with CAN SLIM: accelerating quarterly EPS and margin expansion (C), improving annual earnings and a credible 5-year profit/FCF roadmap (A), multiple new product/technology and contract catalysts plus recent new highs (N), buybacks and strong platform demand (S), leadership characteristics and relative strength (L), robust institutional coverage (I), and a favorable sector trend despite macro crosswinds (M). Risks—tariffs/supply chain, GTF remediation cash flow, and leverage ~2.0x—are acknowledged but manageable with mitigations in place and cash generation inflecting in 2025. Tactically, consider adding on a constructive pullback toward the 50-day (~607p) or on a high-volume breakout above ~683p in line with O’Neil’s rules.